We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$55.8M
Cap. Flow
-$77.9M
Cap. Flow %
-1.94%
Top 10 Hldgs %
16.78%
Holding
730
New
81
Increased
176
Reduced
283
Closed
57

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
VZ icon
Verizon
VZ
+$26.7M
4
LOW icon
Lowe's Companies
LOW
+$25.6M
5
CMI icon
Cummins
CMI
+$20.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$38.5M
2
CL icon
Colgate-Palmolive
CL
+$31.6M
3
LLY icon
Eli Lilly
LLY
+$30.3M
4
HD icon
Home Depot
HD
+$28.5M
5
MSFT icon
Microsoft
MSFT
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.88%
2 Technology 13.15%
3 Financials 10.92%
4 Communication Services 10.03%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
376
NextEra Energy
NEE
$181B
$780K 0.02%
23,932
-2,580
-10% -$77.5K
FRT icon
377
Federal Realty Investment Trust
FRT
$10.7B
$771K 0.02%
4,659
WNR
378
DELISTED
Western Refining Inc
WNR
$771K 0.02%
37,353
-10,450
-22% -$245K
LPL icon
379
LG Display
LPL
$3B
$768K 0.02%
66,245
CWI icon
380
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.78B
$765K 0.02%
37,695
+20,595
+120% +$424K
TCF
381
DELISTED
TCF Financial Corporation Common Stock
TCF
$752K 0.02%
20,162
DBV
382
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$749K 0.02%
30,958
-929
-3% -$21.9K
BSCM
383
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$748K 0.02%
+34,744
New +$737K
DVA icon
384
DaVita
DVA
$15.4B
$743K 0.02%
9,607
+315
+3% +$23.8K
IAU icon
385
iShares Gold Trust
IAU
$62.9B
$739K 0.02%
28,957
-123
-0.4% -$2.99K
TMH
386
DELISTED
Team Health Holdings Inc
TMH
$730K 0.02%
17,950
BAB icon
387
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$725K 0.02%
23,035
+400
+2% +$12.2K
BMO icon
388
Bank of Montreal
BMO
$126B
$719K 0.02%
11,346
-600
-5% -$38K
NKE icon
389
Nike
NKE
$61.9B
$709K 0.02%
12,844
-1,940
-13% -$111K
IBDO
390
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$700K 0.02%
+27,243
New +$686K
GIMO
391
DELISTED
Gigamon Inc.
GIMO
$699K 0.02%
18,705
-2,820
-13% -$89.8K
WLK icon
392
Westlake Corp
WLK
$9.03B
$686K 0.02%
+15,987
New +$730K
CRUS icon
393
Cirrus Logic
CRUS
$6.53B
$684K 0.02%
17,625
+115
+0.7% +$4.12K
WAL icon
394
Western Alliance Bancorporation
WAL
$8.79B
$684K 0.02%
20,940
-61,835
-75% -$2.17M
BYD icon
395
Boyd Gaming
BYD
$6.32B
$672K 0.02%
36,505
+13,810
+61% +$268K
BA icon
396
Boeing
BA
$171B
$667K 0.02%
5,133
ATVI
397
DELISTED
Activision Blizzard
ATVI
$650K 0.02%
16,411
+914
+6% +$33.6K
HBI
398
DELISTED
Hanesbrands
HBI
$646K 0.02%
25,719
-19,386
-43% -$528K
SAIC icon
399
Saic
SAIC
$4.95B
$643K 0.02%
11,020
+85
+0.8% +$4.62K
MDRX
400
DELISTED
Veradigm Inc. Common Stock
MDRX
$640K 0.02%
50,367
+250
+0.5% +$3.31K

Similar funds

Boston Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Advisors held 730 positions worth $4.01B, down 1.4% from $4.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Advisors's Q2 2016 filing shows 81 new, 176 increased, 283 reduced and 57 closed positions. Its largest new stake was Sherwin-Williams: 204,480 shares worth $20M. The largest sale was AbbVie, an estimated $38.5M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q2 2016 buy was Sherwin-Williams: 204,480 shares worth $20M.
  • Boston Advisors added most to Biogen in Q2 2016, an estimated $32.1M increase.
  • Boston Advisors's biggest Q2 2016 reduction was AbbVie, cutting an estimated $38.5M.
  • Boston Advisors fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $23.4M.
  • Boston Advisors's ten largest holdings make up 17% of its $4.01B portfolio in Q2 2016.
  • Boston Advisors opened 81 new positions and closed 57 in Q2 2016.
  • Boston Advisors's portfolio value fell 1.4% quarter-over-quarter to $4.01B.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.